Recro Pharma Inc. (REPH) Rose 25.31% or 1.65 To Price $8.17 On Thursday


Recro Pharma Inc. (REPH) rose 25.31% or 1.65 to $8.17. It is nearly 5.56 million shares traded, which is 1217.11% compare to the average total volume 456549. The market cap of REPH is $179.66 million. The year to date change is 13.3%. The 52 week price range is from $4.78 to $13.05. Price of REPH have changed 12.61% during last week. It have changed -30.79% over last month, -12.01% over last 3 months, -9.44% over last 6 months and -39.74% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for REPH is 8.27. It is 1.22% above current price. The 200-day Moving Averages for REPH is 7.05. It is -13.71% below current price. The 52-week High is 13.05. It is 59.73% from the current price. The 52-week Low is 4.78. It is -41.49% from current price.

There are some statistics of REPH. It is has market cap $179.66 million. The share outstanding is 21.99 million. The average volume is 456549. The percent of top 15 Institution holding is 67.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of REPH is -1705.67%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of REPH is -46.66%.


Tags:

Share this post